The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2016

Filed:

Sep. 12, 2008
Applicants:

Gilles Dadaglio, Chatillen, FR;

Claude Leclerc, Paris, FR;

Daniel Ladant, Cachan, FR;

Benoît Van Den Eynde, Brussels, BE;

Sandra Morel, Brussels, BE;

Cécile Bauche, Paris, FR;

Inventors:

Gilles Dadaglio, Chatillen, FR;

Claude Leclerc, Paris, FR;

Daniel Ladant, Cachan, FR;

Benoît Van Den Eynde, Brussels, BE;

Sandra Morel, Brussels, BE;

Cécile Bauche, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/88 (2006.01); A61K 38/16 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C12N 9/88 (2013.01); A61K 38/164 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 47/4833 (2013.01); A61K 47/48261 (2013.01); C12Y 406/01001 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6068 (2013.01);
Abstract

An immunogenic composition comprising a recombinant protein comprising aCyaA, or a fragment thereof, and a peptide that corresponds to a tumor antigen is provided as a cancer treatment. Methods of treatment with this immunogenic composition are also provided. In an embodiment, the therapeutic composition is a treatment for melanoma, and comprises epitopes from the HLA*0201 epitope. These epitopes include Tyr or GnT-V, and are present in the recombinant proteins CyaA-E5-Tyr and CyaA-E5-GnT-V.


Find Patent Forward Citations

Loading…